MDIC’s staff is available to answer any questions about the consortium. To help direct your question to the right person, areas of focus for each staff member are provided here.
William V. Murray, President & CEO
Bill joined MDIC in August of 2013 as the first President and CEO. He has over 25 years of senior leadership experience spanning the range of privately financed start-up to billion dollar plus global businesses. Bill’s small company experience spans 5 years as CEO and executive consultant, including 3 years as CEO of ReShape Medical. His large company experience includes leadership as the Molecular Biology Division President of Applied Biosystems, and at Medtronic where he spent nearly 20 years in various senior leadership positions, including President of the Pacemaker Business. Bill has also served as interim President and CEO of MTS Systems (MTSC) a public $500M industrial technology company. Bill currently serves on the Boards of MDIC, ILT, Sonex Health and Meso-FLow and previously served on the Boards of MTS Systems, LifeSync Holdings, and ReShape Medical. Bill has also served on various industry association and community leadership boards. He earned a Bachelor of Science Degree in Electrical Engineering from The University of Florida.
Dawn Bardot, PhD, Vice President, Technology Innovation
With more than 15 years of experience in medical devices, Dawn Bardot, PhD, brings a wealth of experience to her role as Vice President of Technology Innovation at the Medical Device Innovation Consortium (MDIC). She is passionate about the application of data analytics and modeling to improve health care and lower the cost of bringing products to market.
Over the course of her career, Bardot has worked with startup companies, government organizations and academia on data driven design and decision making, including high intensity focused ultrasound, patient specific noninvasive FFR and medical oxygen regeneration for space flight. She has tackled the challenge of big data and data curation; disseminated and promoted the first computational model V&V standard; and recruited, hired and led high performing teams of direct reports and volunteers. At MDIC, her programs have produced and demonstrated a statistical framework for incorporating virtual patients in clinical trials including one mock submission, seven retrospective applications and one prospective application.
Dr. Bardot has a BS and MS in mechanical engineering from Kansas State University, a PhD in mechanical engineering from the University of Washington, was an Innovation Fellow at the University of Minnesota Medical Devices Center, and spent two summers as a Faculty Fellow at NASA Marshal Space Flight Center.
Stephanie Christopher, MA, Program Manager, CfQ & PCBR
Stephanie Christopher, MA, has a background in health communication, public health project management and communication education and training. Stephanie joined MDIC in 2013 and manages MDIC’s patient centered benefit-risk assessment, patient engagement and quality initiatives. Prior to joining MDIC, Stephanie worked for seven years with an academic public health team working on interventions to improve the quality of communication between physicians and parents of newborns with abnormal newborn screening results. In 2012-13, Stephanie went on leave from her academic position to do a special assignment for the Food and Drug Administration Center for Devices and Radiological Health (CDRH), updating and training staff on a new risk communication process. Stephanie has also served as an adjunct instructor at Marquette University, teaching introductory communication courses.
Stephanie earned her Bachelor of Arts in Communication-Print Journalism from Pacific Lutheran University in Tacoma, Wash. and Master of Arts in Science, Health, and Environmental Communication from Marquette University in Milwaukee, Wis. Stephanie is also a Certified Clinical Research Coordinator (CCRC) through the Association of Clinical Research Professionals.
Carolyn Hiller, MBA, Program Manager, CDx
Carolyn Hiller joined MDIC as Program Manager to launch their Clinical Diagnostics initiative. She brings diverse experiences in the healthcare sector; in addition to nearly a decade working in the medical device industry, she brings over a decade of executive leadership experience in the non-profit sector including national organizations representing patients, researchers, physicians, and clinical facilities.
Drawing on over 20 years of experience, she uses logic and intuition to achieve success at leading teams, often comprised of members from competing organizations. She has developed programs from conception through phase-out. Her organizational development experience includes facilitating relationships between organizations, increasing volunteer engagement, creating collaborative partnerships, establishing strategies for resource allocation, providing organization-wide strategic direction, and managing risk. She has a particularly strong track record for successfully identifying and launching new programs in emerging markets.
She has worked with physicians to develop and launch profitable educational product lines. She facilitated a summit of 12 national sleep-related organizations for coalition building, and followed up with successfully advocating for a patient-led lobbying coalition that led to establishing the National Center for Sleep Disorders Research within the federal National Institutes of Health NHLBI. She also guided the American Academy of Sleep Medicine’s successful application and acceptance into American Medical Association’s House of Delegates, the principal policy-making body of the AMA.
She holds an MBA from the University of St. Thomas, as well as a BA in Marketing from Metropolitan State University, and an AAS in Animal Health Technology from the University of Minnesota.
Gillian Priddy, Executive Assistant
Gregory F. Molnar, PhD, Consulting Clinical Neuroscientist, CM&S
Dr. Molnar brings to MDIC his 20 years of experience as a medical device innovator and expert in neuromodulation therapies. He trained as a clinical neuroscientist at the University of Toronto, where his research focused on the mechanism of action of deep brain stimulation. Greg has always been passionate about innovations that simplify, and foster patient access, and started his medical device career with a small consulting business in Canada while finishing his studies.
Dr. Molnar holds several patents and publications in the neurostimulation space and leverages his leadership by chairing and serving on various industry, academic and government committees to help advance the field.
Prior to working with MDIC, Dr. Molnar was the director of neuromodulation research at Medtronic plc and was responsible for providing strategic leadership and partnership to his team of scientists and their many internal and external stakeholders to advance our understanding of several therapies including: Deep Brain Stimulation, Spinal Cord Stimulation, Sacral Nerve Stimulation, Gastric Stimulation, and Intrathecal Drug Infusion. Greg has a huge focus on customer engagement and was a primary contact involved with establishing and maintaining research collaborations.
Dr. Molnar is a strong advocate for innovation, championing culture change activities and efforts to bring the various stakeholders together with common goals in the medical device field. He currently serves as an Industrial fellow of the University of Minnesota, a consultant for various firms, and remains active as a neuroscientist.
Dan Schwartz, Program Manager, ACTP
Dan brings award-winning knowledge and experiences spanning twelve years implementing strategic healthcare solutions addressing care delivery, research, therapy adherence, process improvements, and business development.
In that time, Dan has led Health Information Technology (HIT) teams in identifying and implementing best practices for clinical research, care communication, therapy adherence and outcomes. He has won multiple awards implementing Electronic Health Records (EHR/EMR)s, Electronic Data Capture (EDC) tools, and developing a HIT solution automating clinical trial subject adverse event (AE) notifications and therapy adherence. He has assembled and optimized cross-functional medical product (IDE, IND and BLA) clinical research teams to (a) identify stakeholders and track milestones, (b) measure and manage project risks, and (c) achieve project deliverables. Dan established and led the North American Clinical Development Unit (CDU) for a large European medical product sponsor. He managed an integrated health economic outcomes research (HEOR) joint venture between the University of Minnesota, a community hospital, and a private practice. Dan previously held voting member roles on (1) a State-wide commission for anatomical tissue donation, and (2) a community hospital’s Institutional Review Board (IRB).
Dan is pursuing a Master of Science in Health Economics at Johns Hopkins University and earned a Bachelor of Science in Genetics and Cell Development from the University of Minnesota and a Bachelor of Arts in Political Science from Saint John’s University. He spent one year interning as a research assistant in the University of Minnesota’s Stem Cell Institute. In addition, Dan holds certifications as a Six Sigma Green Belt through the Project Management Institute (PMI), and as a Certified Scrum Product Owner (CSPO) through the Scrum Alliance.
Jing Xie, PhD, Vice President, Clinical Affairs
Dr. Xie brings over 15 years of in-depth and hands-on experiences in various aspects of clinical affairs. Her expertise is in clinical strategy, trial design and methodology, market access, data mining and visualization, statistical analysis, and value evidence creation. Over the years she has successfully orchestrated the use of multiple clinical data sources including registries to support device reimbursement and market access.
Prior to joining MDIC, Dr. Xie served as Vice President, Global Clinical Affairs at Zimmer Biomet where she led a global clinical team and oversaw clinical strategy, operation, medical writing, post market surveillance and biostatistics. Over the years in the medical device industry, Dr. Xie has served in various capacities in regulatory and clinical research. One of her earlier assignments at Zimmer Biomet was to develop an Electronic Data Acquisition and Analysis software which is currently being used for both premarket clinical trials and postmarket surveillance studies. Additionally, she worked on developing algorithm for automatic x-ray templating to better predict orthopedic implant sizing. She has been also actively involved in industry activities and served as industry representative on both American Joint Replacement Registry data committee and FORCE TJR steering committees.
Dr. Xie has demonstrated her dexterity in bringing various stakeholders together in collaboration and partnership to further medical device research and expedite product launch. In her role as VP of Clinical Affairs at MDIC, this varied experience involving clinical research, interfacing multiple stakeholders with different priorities and hands-on involvement with data mining will help her bring together various entities to streamline policies that affect clinical trials and expedite product approvals in the US market.
Dr. Xie received a B.S. in Chemistry from Xiamen University, M.S. in Computer Science from Purdue University and a M.S. in Chemistry and a Ph.D. in Materials Science from the University of Alabama.